Metoprolol Succinate Extended Release Tablets

Šalis: Naujoji Zelandija

kalba: anglų

Šaltinis: Medsafe (Medicines Safety Authority)

Veiklioji medžiaga:

Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg

Prieinama:

AFT Pharmaceuticals Ltd

INN (Tarptautinis Pavadinimas):

Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)

Dozė:

23.75 mg

Vaisto forma:

Modified release tablet

Sudėtis:

Active: Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres

Recepto tipas:

Prescription

Pagaminta:

Watson Pharma Private Limited

Terapinės indikacijos:

Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

Produkto santrauka:

Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C

Leidimo data:

2016-06-24